Skip to main content
HR 2025 115th Congress House

Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017

Official title: To amend section 505(c)(3)(E) of the Federal Food, Drug, and Cosmetic Act to prevent certain applications from being considered ineligible for approval under s… Show full official titleShow less

Official title: To amend section 505(c)(3)(E) of the Federal Food, Drug, and Cosmetic Act to prevent certain applications from being considered ineligible for approval under section 505(c) of such Act on the basis that the proposed labeling includes information describing abuse-deterrent properties that otherwise would be blocked by exclusivity under clause (iii) or (iv) of section 503(c)(3)(E) of such Act, and for other purposes.

Introduced: April 6, 2017 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Health Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug, alcohol, tobacco use
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 6, 2017
Referred to the House Committee on Energy and Commerce.
Apr 6, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 7, 2017

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to prevent an application for a new drug from being considered ineligible for approval because its labeling includes information describing abuse-deterrent properties that otherwise would be blocked by market exclusivity provisions.

The Department of Health and Human Services shall issue draft guidance and publish final guidance regarding the award and scope of exclusivity for new drugs with properties designed to deter abuse and the exceptions to such exclusivity.

The bill applies to applications and supplements to applications that are submitted or pending approval on or after January 1, 2017.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2025: Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2025/
MLA
"H.R. 2025: Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2025/.
Bluebook (legal)
H.R. 2025, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2025/.
Markdown link
[H.R. 2025: Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017](https://openamerica.io/bill/115-HR-2025/)
Report a problem